Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule

Reuters2026/08/10 10:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Arcadia Biosciences received a Nasdaq notice on Aug. 4, 2026 for failing the $1 minimum bid price rule.
Noncompliance was triggered by 30 straight sessions below $1, from June 22, 2026 to Aug. 3, 2026.
RKDA keeps trading on the Nasdaq Capital Market while it has until Feb. 1, 2027 to regain compliance.
Compliance requires a closing bid price of at least $1 for 10 consecutive business days, subject to Nasdaq discretion.
A reverse stock split is among options under review; failure to cure could lead to delisting risk.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340664), on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule

You may also like

Crypto prices